Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis-Model of Care
- PMID: 36830266
- PMCID: PMC9952299
- DOI: 10.3390/antibiotics12020355
Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis-Model of Care
Abstract
Infective endocarditis (IE) is a serious infectious disease with significant mortality and morbidity placing a burden on healthcare systems. Outpatient antimicrobial therapy in selected patients has been shown to be safe and beneficial to both patients and the healthcare system. In this article, we review the literature on the model of care for outpatient parenteral antimicrobial therapy in infective endocarditis and propose that systems of care be developed based on local resources and all patients admitted with infective endocarditis be screened appropriately for outpatient antimicrobial therapy.
Keywords: OPAT; infective endocarditis; multidisciplinary team.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Outpatient Antimicrobial Therapy for Infective Endocarditis is Safe.Heart Lung Circ. 2021 Feb;30(2):207-215. doi: 10.1016/j.hlc.2020.08.016. Epub 2020 Oct 9. Heart Lung Circ. 2021. PMID: 33041197 Review.
-
Efficacy and safety of outpatient parenteral antibiotic therapy in patients with infective endocarditis: a meta-analysis.Rev Esp Quimioter. 2022 Aug;35(4):370-377. doi: 10.37201/req/011.2022. Epub 2022 Jun 2. Rev Esp Quimioter. 2022. PMID: 35652306 Free PMC article.
-
Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy.Med Mal Infect. 2014 Jul;44(7):327-30. doi: 10.1016/j.medmal.2014.05.001. Epub 2014 Jul 9. Med Mal Infect. 2014. PMID: 25022891
-
Clinical predictors of outcome in patients with infective endocarditis receiving outpatient parenteral antibiotic therapy (OPAT).J Infect. 2021 Dec;83(6):644-649. doi: 10.1016/j.jinf.2021.09.021. Epub 2021 Oct 3. J Infect. 2021. PMID: 34614400
-
Outpatient treatment of endocarditis in a clinic-based program in Argentina.Eur J Clin Microbiol Infect Dis. 1995 Jul;14(7):648-54. doi: 10.1007/BF01690747. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7588859 Review.
Cited by
-
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177. J Antimicrob Chemother. 2024. PMID: 38842523 Free PMC article. Review.
-
Patients' Perspectives on Alternative Antibiotic Treatment Strategies for Infective Endocarditis Among Persons Who Inject Drugs.J Addict Med. 2025 Jul 17:10.1097/ADM.0000000000001545. doi: 10.1097/ADM.0000000000001545. Online ahead of print. J Addict Med. 2025. PMID: 40673603 Free PMC article.
References
-
- Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., Erwin J.P., 3rd, Gentile F., Jneid H., Krieger E.V., Mack M., McLeod C., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Thorac. Cardiovasc. Surg. 2014;148:e1–e132. doi: 10.1016/j.jtcvs.2014.05.014. - DOI - PubMed
-
- Pajarón M., Fernández-Miera M.F., Allende I., Arnaiz A.M., Gutiérrez-Cuadra M., Cobo-Belaustegui M., Armiñanzas C., de Berrazueta J.R., Fariñas M.C., Sanroma P. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: A safe and effective model. Eur. J. Intern. Med. 2015;26:131–136. doi: 10.1016/j.ejim.2015.01.001. - DOI - PubMed
LinkOut - more resources
Full Text Sources